JMPWA
PTX

JP Morgan Private Wealth Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,148
Closed -$5K – 1309
2016
Q2 		$5K Hold
1,148
– – ﹤0.01% 1250
2016
Q1 		$12K Hold
1,148
– – ﹤0.01% 1233
2015
Q4 		$34K Sell
1,148
-370
-24% -$11.2K ﹤0.01% 1101
2015
Q3 		$48K Buy
+1,518
New +$72.6K ﹤0.01% 1025

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PTX Position: Q3 2016 in Review

JP Morgan Private Wealth Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 1,148 shares — an estimated $5K sold.

JP Morgan Private Wealth Advisors first reported a position in PTX in Q3 2015 and held it in 4 quarters. The position peaked at $48K in Q3 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • JP Morgan Private Wealth Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 1,148 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $5K.
  • JP Morgan Private Wealth Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2015 and held it in 4 quarters.
  • JP Morgan Private Wealth Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $48K in Q3 2015.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.